Skip to content 
Qiagen N.V. provides sample to insight solutions that transform biological samples into molecular insights in the Netherlands and internationally. The company offers primary sample technology consumables, such as nucleic acid stabilization and purification kits for sample materials, manual and automated processing for genotyping, gene expression, and viral and bacterial analysis, as well as silica membranes and magnetic bead technologies; secondary sample technology consumables, such as kits and components for purification of nucleic acids; and instruments for nucleic acid purification, quality control, and accessories. It also provides Immune response consumables, such as interferon-gamma release assay for TB testing, and assays for post-transplant testing and viral load monitoring; oncology and sexual and reproductive health consumables, such as assays for prenatal testing and detection of sexually transmitted diseases and HPV; assays for analysis of genomic variants; and sample to insight instruments, including one-step molecular analysis of hard-to-diagnose syndromes, and integrated PCR testing. The company offers research PCR consumables, such as quantitative PCR, reverse transcription, and combinations kits for analysis of gene expression, genotyping and gene regulation, and running on QIAGEN instruments and technologies; human ID/forensics assay consumables, such as short tandem repeat assays for human ID, and assays for food contamination; PCR instruments, including digital PCR and qPCR solutions; and developed and configured enzymes and PCR solutions. It offers NGS gene panels, library prep kits and components, and whole genome amplification; QIAGEN consumables and instruments; bioinformatics solutions; and custom laboratory and genomic services. The company provides software-as-a-service. It serves molecular diagnostics, academia, pharmaceutical, and applied testing customers. The company was founded in 1984 and is headquartered in Venlo, the Netherlands. more
| Time Frame | QGEN | Sector | S&P500 |
|---|---|---|---|
| 1-Week Return | -1.06% | -1.08% | -1.38% |
| 1-Month Return | 6.8% | -0.47% | -1.81% |
| 3-Month Return | 12.9% | 2.13% | 1.38% |
| 6-Month Return | 2.4% | 17.04% | 5.68% |
| 1-Year Return | 25.84% | 6.56% | 11.74% |
| 3-Year Return | 0.01% | 16.78% | 65.15% |
| 5-Year Return | -11.52% | 34.34% | 73.68% |
| 10-Year Return | 126.58% | 137.88% | 260.03% |
| Dec '21 | Dec '22 | Dec '23 | Dec '24 | Dec '25 | 5YR TREND | |
|---|---|---|---|---|---|---|
| Total Revenue | 2.25B | 2.14B | 1.97B | 1.98B | 2.09B | [{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":95.11,"profit":true},{"date":"2023-12-31","value":87.28,"profit":true},{"date":"2024-12-31","value":87.86,"profit":true},{"date":"2025-12-31","value":92.82,"profit":true}] |
| Cost of Revenue | 800.84M | 756.96M | 731.62M | 1.01B | 798.50M | [{"date":"2021-12-31","value":79.22,"profit":true},{"date":"2022-12-31","value":74.88,"profit":true},{"date":"2023-12-31","value":72.38,"profit":true},{"date":"2024-12-31","value":100,"profit":true},{"date":"2025-12-31","value":78.99,"profit":true}] |
| Gross Profit | 1.45B | 1.38B | 1.23B | 967.35M | 1.29B | [{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":95.43,"profit":true},{"date":"2023-12-31","value":85.03,"profit":true},{"date":"2024-12-31","value":66.68,"profit":true},{"date":"2025-12-31","value":89.02,"profit":true}] |
| Gross Margin | 64.43% | 64.65% | 62.77% | 48.90% | 61.79% | [{"date":"2021-12-31","value":99.66,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":97.09,"profit":true},{"date":"2024-12-31","value":75.63,"profit":true},{"date":"2025-12-31","value":95.58,"profit":true}] |
| Operating Expenses | 820.74M | 853.10M | 823.75M | 869.64M | 771.18M | [{"date":"2021-12-31","value":94.38,"profit":true},{"date":"2022-12-31","value":98.1,"profit":true},{"date":"2023-12-31","value":94.72,"profit":true},{"date":"2024-12-31","value":100,"profit":true},{"date":"2025-12-31","value":88.68,"profit":true}] |
| Operating Income | 630.08M | 531.46M | 409.94M | 97.71M | 520.31M | [{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":84.35,"profit":true},{"date":"2023-12-31","value":65.06,"profit":true},{"date":"2024-12-31","value":15.51,"profit":true},{"date":"2025-12-31","value":82.58,"profit":true}] |
| Total Non-Operating Income/Expense | (49.17M) | (44.46M) | 40.02M | 47.61M | - | [{"date":"2021-12-31","value":-103.28,"profit":false},{"date":"2022-12-31","value":-93.38,"profit":false},{"date":"2023-12-31","value":84.06,"profit":true},{"date":"2024-12-31","value":100,"profit":true},{"date":"2025-12-31","value":"-","profit":true}] |
| Pre-Tax Income | 625.83M | 512.60M | 429.81M | 121.15M | 490.26M | [{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":81.91,"profit":true},{"date":"2023-12-31","value":68.68,"profit":true},{"date":"2024-12-31","value":19.36,"profit":true},{"date":"2025-12-31","value":78.34,"profit":true}] |
| Income Taxes | 113.23M | 89.39M | 88.51M | 37.56M | 65.39M | [{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":78.94,"profit":true},{"date":"2023-12-31","value":78.16,"profit":true},{"date":"2024-12-31","value":33.17,"profit":true},{"date":"2025-12-31","value":57.74,"profit":true}] |
| Income After Taxes | 512.60M | 423.21M | 341.30M | 83.59M | - | [{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":82.56,"profit":true},{"date":"2023-12-31","value":66.58,"profit":true},{"date":"2024-12-31","value":16.31,"profit":true},{"date":"2025-12-31","value":"-","profit":true}] |
| Income From Continuous Operations | 512.60M | 423.21M | 332.48M | 83.59M | - | [{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":82.56,"profit":true},{"date":"2023-12-31","value":64.86,"profit":true},{"date":"2024-12-31","value":16.31,"profit":true},{"date":"2025-12-31","value":"-","profit":true}] |
| Income From Discontinued Operations | - | - | - | - | - | [{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true},{"date":"2025-12-31","value":"-","profit":true}] |
| Net Income | 512.60M | 423.21M | 341.30M | 83.59M | 424.88M | [{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":82.56,"profit":true},{"date":"2023-12-31","value":66.58,"profit":true},{"date":"2024-12-31","value":16.31,"profit":true},{"date":"2025-12-31","value":82.89,"profit":true}] |
| EPS (Diluted) | 2.97 | 2.64 | 2.30 | 2.22 | 2.47 | [{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":88.89,"profit":true},{"date":"2023-12-31","value":77.44,"profit":true},{"date":"2024-12-31","value":74.75,"profit":true},{"date":"2025-12-31","value":83.16,"profit":true}] |
These ratios help you determine the liquidity of the company. Higher is better.
| QGEN | |
|---|---|
| Cash Ratio | 2.15 |
| Current Ratio | 3.90 |
| Quick Ratio | 3.31 |
These ratios help you understand the company's efficiency in using its assets to generate returns. Higher is better. For ROE, average long term is around 14%, less than 10% is poor.
| QGEN | |
|---|---|
| ROA (LTM) | 5.76% |
| ROE (LTM) | 11.57% |
These ratios help you understand the company's liabilities, gauging the riskiness of the investment.
| QGEN | |
|---|---|
| Debt Ratio Lower is generally better. Negative is bad. | 0.40 |
| Common Equity/Total Assets Higher is better. Lower can suggest investment is riskier. | 0.60 |
These ratios help you understand the company's valuation. Lower may indicate cheaper stocks.
| QGEN | |
|---|---|
| Trailing PE | 24.71 |
| Forward PE | 18.05 |
| P/S (TTM) | 4.97 |
| P/B | 2.77 |
| Price/FCF | 89 |
| EV/R | 5.28 |
| EV/Ebitda | 15.38 |
| PEG | 0.34 |
Qiagen NV (QGEN) share price today is $50.41
Yes, Indians can buy shares of Qiagen NV (QGEN) on Vested. To buy
Yes, you can purchase fractional shares of Qiagen NV (QGEN) via the Vested app. You can start investing in Qiagen NV (QGEN) with a minimum investment of $1.
You can invest in shares of Qiagen NV (QGEN) via Vested in three simple steps:
The 52-week high price of Qiagen NV (QGEN) is $57.82. The 52-week low price of Qiagen NV (QGEN) is $35.53.
The price-to-earnings (P/E) ratio of Qiagen NV (QGEN) is
The price-to-book (P/B) ratio of Qiagen NV (QGEN) is 2.77
The dividend yield of Qiagen NV (QGEN) is 0.52%
The market capitalization of Qiagen NV (QGEN) is $10.48B
The stock symbol (or ticker) of Qiagen NV is QGEN
Consider the share price of Qiagen NV as a long-term story and not a daily point list. The price represents a movement of the stock in both good and bad times when looked at over many years. This assists the investors to know whether Qiagen NV has succeeded to expand steadily and overcome market declines. With this price movement observed and the way the business is progressing, it is easier to make a decision whether the stock is worth having in the long term or not.
When investing in Qiagen NV shares, you are not based in India then your investment is not just based on the stock price. It is also determined by the currency movement of the dollar in relation to the rupee. When you have an appreciation of the Qiagen NV stock and the dollar appreciation is also the same, you gain more in terms of rupees. When the rupee appreciated, it will lower your profits. This currency flow is a silent cause of great contribution to your ultimate returns over many years.
Rather than merely checking the share price of Qiagen NV and comparing it with that of other stocks in the same sector, one can check how robust the business is. Investors tend to compare such aspects as profits, cash generation, and the stability of the revenues of the company. This means that Qiagen NV stock in most cases does not react in the same manner as other companies in the sector due to its brand and services revenue.
Link copied 
